2024年7月8日 · Blinatumomab (Blincyto) is an injectable immunotherapy treatment that may be used to treat B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children aged …

Blinatumomab, sold under the brand name Blincyto, is a biopharmaceutical medication used for the treatment of Philadelphia chromosome -negative relapsed or refractory acute …

WHAT IS BLINCYTO ® (blinatumomab)? B-cell precursor acute lymphoblastic leukemia (ALL) in remission when only a small number of cancer cells remain in the body (minimal residual …

2024年10月23日 · Blincyto (blinatumomab) is commonly used to treat certain acute lymphoblastic leukemia (ALL) cancers. Blincyto may also be used for other conditions as determined by your …

2017年3月2日 · In this multi-institutional phase 3 trial, we randomly assigned adults with heavily pretreated B-cell precursor ALL, in a 2:1 ratio, to receive either blinatumomab or standard-of …

2024年7月24日 · Many older adults with B-cell precursor acute lymphoblastic leukemia (BCP-ALL) have a relapse despite having a measurable residual disease (MRD)–negative complete …

Blinatumomab is a type of immunotherapy drug called a bispecific T-cell engager (BiTE). FDA label information for this drug is available at DailyMed. Blinatumomab is approved to treat: B …

2023年1月25日 · Blinatumomab is a type of immunotherapy called a bispecific T-cell engager (BiTE). It simultaneously attaches to T cells and cancer cells, enabling T cells to easily find …

2021年4月1日 · Blinatumomab, a type of immunotherapy, binds to certain molecules on leukemia cells and T cells, bringing the T cells close enough to the leukemia cells to kill them.

2022年12月12日 · What is this drug used for? It is used to treat a type of leukemia. What do I need to tell my doctor BEFORE I take this drug? If you are allergic to this drug; any part of this …